139 related articles for article (PubMed ID: 31278627)
1. Relation of Blood Arsenic Concentration with Effect and Safety of Arsenic-Containing Qinghuang Powder () in Patients with Myelodysplastic Syndrome.
Deng ZY; Zhu SR; Wang MJ; Fang S; Zhao P; Zhu QZ; Wang HZ; Guo XQ; Xu YG; Yi BW; Shang XH; Ma R; Hu XM
Chin J Integr Med; 2019 Jul; 25(7):497-501. PubMed ID: 31278627
[TBL] [Abstract][Full Text] [Related]
2. Oral Arsenic-Containing Qinghuang Powder: A Potential Drug for Myelodysplastic Syndromes.
Ming J; Liu WY; Xiao HY; Xu YG; Ma R; Hu XM
Chin J Integr Med; 2022 Aug; 28(8):762-768. PubMed ID: 32146594
[TBL] [Abstract][Full Text] [Related]
3. Study on the Clinical Safe and Effective Methods of Arsenic-Containing Compound-Qinghuang Powder in the Treatment of Myelodysplastic Syndrome.
Zhu Q; Deng Z; Zhu S; Zhao P; Wang M; Hu X
Evid Based Complement Alternat Med; 2017; 2017():2095682. PubMed ID: 29348764
[TBL] [Abstract][Full Text] [Related]
4. Association of Gene Mutations with Response to Arsenic-Containing Compound Qinghuang Powder () in Patients with Myelodysplastic Syndromes.
Zhao P; Liang JB; Deng ZY; Wang MJ; Qin JY; Chen CJ; Hu XM
Chin J Integr Med; 2019 Jun; 25(6):409-415. PubMed ID: 29619748
[TBL] [Abstract][Full Text] [Related]
5. Effect of Qinghuang Powder () Combined with Bupi Yishen Decoction () in Treating Patients with Refractory Cytopenia with Multilineage Dysplasia through Regulating DNA Methylation.
Zhou QB; Yang XH; Wang HZ; Wang DX; Xu YG; Hu XM; Xu FQ; Ma R
Chin J Integr Med; 2019 May; 25(5):354-359. PubMed ID: 29500545
[TBL] [Abstract][Full Text] [Related]
6. Arsenic-Containing Qinghuang Powder () is an Alternative Treatment for Elderly Acute Myeloid Leukemia Patients Refusing Low-Intensity Chemotherapy.
Fan T; Quan RC; Liu WY; Xiao HY; Tang XD; Liu C; Li L; Lv Y; Wang HZ; Xu YG; Guo XQ; Hu XM
Chin J Integr Med; 2020 May; 26(5):339-344. PubMed ID: 31848890
[TBL] [Abstract][Full Text] [Related]
7. Clinical observation of the treatment of myelodysplastic syndrome mainly with Qinghuang Powder.
Xu S; Ma R; Hu XM; Xu YG; Yang XH; Wang HZ; Sun SZ; Liu F
Chin J Integr Med; 2011 Nov; 17(11):834-9. PubMed ID: 22057412
[TBL] [Abstract][Full Text] [Related]
8. [Effect of treatment for hypocellular myelodysplastic syndromes by a low dose qinghuang powder combined with Chinese drugs for Shen supplementing and Pi invigorating: a clinical observation].
Zhou QB; Wang HZ; Gao F; Tang XD; Xu S; Yang XH; Xu YG; Hu XM; Ma R
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Dec; 34(12):1444-8. PubMed ID: 25632743
[TBL] [Abstract][Full Text] [Related]
9. [Effect of Qinghuang Powder combined Chinese herbs for Pi-strengthening and Shen-reinforcing on HIF-1alpha in bone marrow mononuclear cells of myelodysplastic syndrome patients: an experimental research].
Gao F; Xu YG; Yang XH; Ma R
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Feb; 34(2):174-8. PubMed ID: 24672941
[TBL] [Abstract][Full Text] [Related]
10. Arsenic concentration in peripheral blood is correlated with efficacy of a Traditional Chinese Medicine regimen containing realgar for the treatment of myelodysplastic syndrome.
Wang DX; Xu YG; Du Y; Wang HZ; Li L; Hu XM; Yang XP; Ma R; Zhou QB
J Tradit Chin Med; 2021 Aug; 41(4):630-635. PubMed ID: 34392657
[TBL] [Abstract][Full Text] [Related]
11. [Effect of treatment for myelodysplastic syndrome by Qinghuang Powder combined with Chinese herbs for reinforcing shen and strenghening pi].
Xu S; Hu XM; Xu YG
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Mar; 28(3):216-8. PubMed ID: 18476419
[TBL] [Abstract][Full Text] [Related]
12. [Effects of qinghuang power combined Chinese herbs for shen reinforcing and Pi strengthening on activated T cells of myelodysplastic syndrome patients].
Gao F; Ma R; Yang XH; Xu YG
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Apr; 33(4):443-7. PubMed ID: 23841258
[TBL] [Abstract][Full Text] [Related]
13. Application and assessment of Chinese arsenic drugs in treating malignant hematopathy in China.
Hu XM; Liu F; Ma R
Chin J Integr Med; 2010 Aug; 16(4):368-77. PubMed ID: 20697951
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.
Vey N; Bosly A; Guerci A; Feremans W; Dombret H; Dreyfus F; Bowen D; Burnett A; Dennis M; Ribrag V; Casadevall N; Legros L; Fenaux P
J Clin Oncol; 2006 Jun; 24(16):2465-71. PubMed ID: 16651646
[TBL] [Abstract][Full Text] [Related]
15. Comparing Arsenic-Containing Qinghuang Powder and Low-Intensity Chemotherapy in Elderly Patients with Acute Myeloid Leukemia.
Chin J Integr Med; ; . PubMed ID: 37222831
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]